Targeting IL-23: emerging possibilities in the management of Crohn’s disease (AbbVie) - Inhibition of IL-23: a pathway worth exploring
James O. Lindsay 1
1 Digestive Disorders Clinical Academic Unit, BARTS & THE LONDON SCHOOL OF MEDICINE
Conference
UEG Week Virtual 2020
Publisher
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
New to myUEG?
Social Sharing